February 21 2019
NRG Oncology NCORP is soliciting PILOT projects for applications focused on NRG NCORP Cancer Prevention and Control (CPC) priorities that will provide data that will directly lead to future Phase II-III CPC concepts. As put forward in our core grant, CPC priorities for funding include cancer prevention research and cancer control investigation aimed at understanding and/or ameliorating the symptoms and toxicity related to:
- Neurocognitive function
- Gender specific symptom reduction
- Behavioral interventions
- Treatment dose alterations or delivery
- Cancer risk reduction
- Chemotherapy induced peripheral neuropathy
For full details read more
NRG Oncology NCORP solicits PILOT projects addressing NRG NCORP Cancer Care Delivery Research (CCDR)priorities. CCDR funding priorities are:
- Implementation and dissemination interventions related to guideline based care:
- Use of tumor DNA sequencing prior to prescribing targeted therapies(<1/4 of CCDR practices report routine use);
- Integrating patient-reported outcomes into clinical practice (extends survival);
- Enhance access to proven survivorship and palliative care strategies optimizing survivor and family quality of life;
- Optimize screening strategies based on disease risk including patients in the post-treatment surveillance phase of care; and
- Implement evidence-based symptom management strategies addressing patients’ needs during both active adjuvant and palliative treatment.
- Patient-reported outcomes (PROs) related to symptom management: The CCDR committee will prioritize proposals including the PRO-CTCAE in NRG NCORP trials, and improve compliance and data capture. The CCDR committee also encourages studies employing technology or apps to standardized PRO variables across EHR, registry, and claims data systems.
For full details read more